medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2007, Número 10

<< Anterior Siguiente >>

Ginecol Obstet Mex 2007; 75 (10)


Recomendaciones generales para el tratamiento en la transición perimenopáusica

Neyro JL, Castelo BC, Quereda F, Cancelo MJ, Elorriaga MÁ, Palacios S

Idioma: Español
Referencias bibliográficas: 45
Paginas: 573-581
Archivo PDF: 168.09 Kb.


RESUMEN

Antecedentes: la atención médica en la perimenopausia requiere la utilización de distintos recursos terapéuticos.
Objetivo: definir estrategias para la atención de la mujer perimenopáusica que favorezcan un envejecimiento saludable.
Método: revisión de los factores y las modificaciones del estilo de vida que pueden prevenir enfermedades en la perimenopausia.
Resultados: la composición de la dieta y el control del peso influyen en el riesgo cardiovascular y óseo. Es difícil conseguir cambios permanentes en los hábitos dietéticos y faltan datos concluyentes sobre los resultados de estas recomendaciones, pero comienzan a surgir trabajos de mayor calidad que muestran el beneficio cardiovascular y óseo de la actividad física y los programas específicos de ejercicio. Es necesario suprimir los hábitos tóxicos, dado el mayor riesgo que implican. Múltiples estudios sugieren el beneficio de consumir complementos fitoterapéuticos, pero faltan ensayos clínicos bien diseñados que justifiquen esa recomendación.
Conclusiones: el correcto estado nutricional, una dieta adecuada, el control del peso, la práctica habitual de ejercicio y la supresión de hábitos tóxicos son medidas aplicables en la transición perimenopáusica que pueden mejorar la salud de la mujer durante el resto de su vida. La identificación individualizada del riesgo de enfermedades justifica las recomendaciones.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Li C, Samsioe G, Borgfeldt C, Lidfeldt J, et al. Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women’s Health in Lund Area Study). Am J Obstet Gynecol 2003;189(6):1646-53.

  2. Whiteman MK, Staropoli CA, Langenberg PW, McCarter RJ, et al. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol 2003;101(2):264-72.

  3. North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11(1):11-33.

  4. Programas de Actividades Preventivas y Promoción de la Salud (PAPPS). Red de Centros de Investigadores de la Sociedad Española de Medicina Familiar y Comunitaria (SEMFYC), 1999. http://www.papps.org/index.htm

  5. Sociedad Española de Ginecología y Obstetricia. Situación actual de la menopausia en España. Documento de consenso sobre terapia hormonal. SEGO 2003 y recomendaciones AEEM. www.sego.es y www.aeem.es (consultado 10-12-2005).

  6. Ferrer J, Neyro JL, Estevez A. Identification of risk factors for prevention and early diagnosis of asymptomatic postmenopausal women. Maturitas 2005;52(Suppl. 1):S7-22.

  7. Neyro JL, Cancelo MJ, Quereda F, Palacios S, et al (NAMS group of the AEEM). Relevance of the results of the Women’s Health Initiative on the prescription of hormone therapy in Spain. Climacteric 2005;8:36-48.

  8. The implementation of nutritional advice for people with diabetes. Nutrition Subcommittee of the Diabetes Care Advisory Committee of Diabetes UK. Diabet Med 2003;20:786-807.

  9. Gold EB, Stemfeld B, Kelsey JL, Brown C, et al. Relation of demographic and life style factors to symptoms in a multiracial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152(5):463-73.

  10. American Heart Association meeting report. Vascular structure and function improve with diet and exercise, 6th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, 2005. http://www.eurekalert.org/pub_releases/2005-04/ahavsa042105.php

  11. Martinez-Gonzalez MA, Estruch R. Mediterranean diet, antioxi- dants and cancer: the need for randomized trials. European Journal of Cancer Prevention 2004;13:327-35.

  12. Estruch R, Ros E, Covas I, Martínez MA, et al. Eficacia de una dieta tipo mediterráneo en la prevención primaria de la enfermedad cardiovascular. Estudio PREDIMED. http://www.predimed.org/default_principal.asp?idx=&cidioma=2 (consultado 15-12-2005).

  13. Villar F, Banegas JR, De Mata J. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras, 2003. Editores: Astra Zéneca y Sociedad Española de Arterioesclerosis (SEA).

  14. Cumming RG, Nevitt MC. Calcium for prevention of osteoporoticfractures in postmenopausal women. J Bone Miner Res 1997;12(9):1321-9.

  15. Michaelsson K, Melhus H, Bellocco R, Wolk A. Dietary calcium and vitamin D intake in relation to osteoporotic fracture risk. Bone 2003;32(6):694-703.

  16. Feskanich D, Willett WC, Colditz GA. Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women. Am J Clin Nutr 2003;77(2):504-11.

  17. Pignone MP, Ammerman A, Fernandez L, Orleans CT, et al. Counseling to promote a healthy diet in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Am J Prev Med 2003;24(1):75-92.

  18. McTigue K, Harris R, Hemphill MB, Bunton AJ, et al. Screening and interventions for overweight and obesity in adults. http://www.ahcpr.gov/clinic/serfiles.htm (consultado 11-01-2006).

  19. Hunt MK, Lobb R, Delichatsios HK, Stone C, et al. Process evaluation of a clinical preventive nutrition intervention. Prev Med 2001;33(2 Pt. 1):82-90.

  20. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991;53:189S-193S.

  21. Cook NR, Stampfer MJ, Ma J, Manson JE, et al. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 1999;86(9):1629-31.

  22. Omenn GS, Goodman GE, Thornquist MD, Balmes J, et al. Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial. J Natl Cancer Inst 1996;88:1550-9.

  23. Morris CD, Carson S. Routine vitamin supplementation to prevent cancer and cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139:56-70.

  24. Slaven L, Lee C. Mood and symptom reporting among middleaged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol 1997;16(3):203-8.

  25. Hammar M, Berg G, Lindgren R. Does physical exercise influences the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990;69(5):409-12.

  26. Kelley GA, Kelley KS, Tran ZV. Exercise and lumbar spine bone mineral density in postmenopausal women: a metaanalysis of individual patient data. J Gerontol A Biol Sci Med Sci 2002;57(9):M599-604.

  27. Krall EA, Dawson-Hughes B, Papas A, Garcia RI. Tooth loss and skeletal bone density in healthy postmenopausal women. Osteoporos Int 1994;4(2):104-9.

  28. Fielding RA. The role of progressive resistance training and nutrition in the preservation of lean body mass in the elderly. J Am Coll Nutr 1995;14(6):587-94.

  29. Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 2002;288(18):2300-6.

  30. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, et al. Effects of the amount and intensity of exercise on plasma lipoproteins N Engl J Med 2002;347(19):1483-92.

  31. Kushi LH, Fee RM, Folsom AR, Mink PJ, et al. Physical activity and mortality in postmenopausal women. JAMA 1997;277(16):1287-92.

  32. Thompson PD, Lim V. Physical activity in the prevention of atherosclerotic coronary heart disease. Curr Treat Options Cardiovasc Med 2003;5(4):279-85.

  33. Lapidus L, Andersson H, Bengtsson C, Bosaeus I. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Clin Nutr 1986;44(4):444-8.

  34. Eakin EG, Glasgow RE, Riley KM. Review of primary carebasedphysical activity intervention studies: effectiveness and implications for practice and future research. J Fam Pract 2000;49(2):158-68.

  35. Swinburn BA, Walter LG, Arroll B, Tilyard MW, Russell DG. The green prescription study: a randomized controlled trial of written exercise advice provided by general practitioners. Am J Public Health 1998;88(2):288-91.

  36. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997;315(7112):841-6.

  37. Vestergaard P, Mosekilde L. Fracture risk associated with smoking: a meta-analysis. J Intern Med 2003;254(6):572-83.

  38. Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM. Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 2004;79(1):155-65.

  39. Cancelo MJ, Palacios S, Castelo-Branco C, Quereda F, et al. Clinical effects on climacteric symptoms of a compound containing isoflavones, pimrose oil and vitamin E administered at two different times. Abstracts of the 11th World Congress on The Menopause, Climacteric 2005;19(4):4-14.

  40. Munro IC, Harwood M, Hlywka JJ, Stephen AM, et al. Soy isoflavones: a safety review. Nutr Rev 2003;61(1):1-33.

  41. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333(5):276-82.

  42. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(Suppl. 1):S67-77.

  43. Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2003;84(2-3):259-68.

  44. Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 2003;10(5):465-76.

  45. Durán M, Allué J, Beltrán E, Bris JM, et al, (Asociación Española para el Estudio de la Menopausia, AEEM). Posicionamiento sobre la fitoterapia en la menopausia. Barcelona, 2004. Prog Obstet Ginecol 2005;48(10):487-9.




2020     |     www.medigraphic.com